Cannabinoids for Low Back Pain and Migraine: What Randomized Trials Actually Show
medical cannabis research: A systematic review of five randomized trials found mixed cannabinoid results: promising signals for vaporized THC plus CBD in acute migraine and VER-01 in chronic low back pain, but no class-wide effect. It keeps the evidence…
Pancreatic Cancer Cannabis Trial Finds Modest THC Dose Signals for Anxiety and Sleep
medical cannabis research: CANPAN pilot data suggest personalized medical cannabis may help selected pancreatic cancer patients, with higher THC exposure linked to anxiety and insomnia improvement, but missing data and small numbers limit certainty. It…
Medical Cannabis Dose and Symptom Control in Pancreatic Cancer
medical cannabis research: CANPAN pilot data suggest low daily THC doses may relate to better anxiety and insomnia scores in pancreatic cancer, but missing data and small sample size require careful interpretation. It keeps the evidence readable for…
Medical Cannabis Dose Patterns and Symptom Control in Pancreatic Cancer
medical cannabis research: CANPAN pilot data suggest modest THC dosing may relate to anxiety, insomnia, and multi-symptom improvement in pancreatic cancer, while also exposing major feasibility challenges in advanced cancer research. It keeps the…
What CANPAN Suggests About THC Dose and Symptoms in Pancreatic Cancer
medical cannabis research: A small CANPAN analysis links higher daily THC exposure with better anxiety and insomnia scores in pancreatic cancer, while also exposing major feasibility and missing-data challenges for future trials. It keeps the evidence…
Intranasal lipid carrier cannabidiol for Dravet and Lennox-Gastaut syndromes remains promising but unproven
medical cannabis research: A new review argues that intranasal nanostructured lipid carrier CBD could improve brain delivery for severe pediatric epilepsies, but the evidence remains preclinical and not yet patient-ready. It keeps the evidence readable…
Nose to Brain CBD Nanocarriers for Dravet and Lennox Gastaut Syndromes
medical cannabis research: A new review argues that intranasal nanostructured lipid CBD could improve brain delivery for severe childhood epilepsies, but the concept remains preclinical and unproven in children. It keeps the evidence readable for…
Intranasal CBD Nanocarriers for Dravet and Lennox Gastaut Syndromes
medical cannabis research: A new review argues that intranasal nanostructured lipid CBD could improve brain delivery for severe childhood epilepsies, but human pediatric safety, dosing, and efficacy data remain absent. It keeps the evidence readable for…
Intranasal CBD Nanocarriers for Dravet and Lennox-Gastaut Syndromes, Promise Before Proof
medical cannabis research: A 2026 review argues that intranasal nanostructured lipid CBD could improve brain delivery for severe childhood epilepsies, but the clinical evidence remains preclinical and translational. It keeps the evidence readable for…
